Clarity Pharmaceuticals was featured in Pharma R&D Today by Elsevier, a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals.
“We believe in personalized medicine and the development of new therapies that are more effective and have less side effects. At Clarity, we recognized that radiopharmaceuticals have this potential and are keen to continue exploring this in collaboration with thought leaders in the field.”
Read the full article here:
https://pharma.elsevier.com/pharma-rd/start-up-spotlight-clarity-pharmaceuticals/
